Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. New solution to treat obstructive sleep apnea

New solution to treat obstructive sleep apnea

Stories Apr 22, 2025 3 minutes

Researchers are developing an effective, affordable and more comfortable treatment to prevent upper airway obstruction during sleep.

People with obstructive sleep apnea (OSA) experience a complete stoppage or a transient reduction in breathing while asleep, which can cause disabling symptoms and long-term health consequences. Current treatments are effective; however, many individuals stop using them due to discomfort, placing them at greater risk of the negative health effects of untreated OSA. 

Dr. John Fleetham is a professor and clinician-scientist at the University of British Columbia (UBC) and a member of the Centre for Lung Health. Fleetham was appointed to the Order of Canada in 2023.

Vancouver Coastal Health Research Institute researcher Dr. John Fleetham and other UBC team members — Dr. Robin Coope, Paul Cubbon, Dr. John Madden and Dr. Lorne Whitehead — are developing a negative airway therapy device that would provide a novel alternative treatment for OSA.

“Our prototype would be akin to a nasal passage opening strip for the neck,” explains Fleetham. “We are designing it to be an effective, comfortable and a more affordable treatment for people with OSA.”

OSA affects approximately 25 per cent of British Columbians, with around five per cent experiencing moderate to severe OSA.

The present recommended treatment for OSA is a continuous positive airway pressure (CPAP) device, which includes a mask worn on the face during sleep. The machine blows air through a tube connected to the mask into the patient’s upper airway, preventing upper airway obstruction.

“When you sleep, all of your muscles relax,” explains Fleetham. “In people with OSA, the relaxing of muscles in the upper airway during sleep closes off the flow of air, leading to recurrent upper airway obstruction and associated asphyxiation.”

The prototype in development by Fleetham and the UBC team would fit over the neck of patients and use negative pressure to keep the upper airway open during sleep.

Negative pressure therapy could increase OSA treatment uptake 

Untreated OSA can lead to an increased risk of heart attack, stroke, depression, high blood pressure, sleepiness, infection and cancer. Despite these risks, many people with OSA discontinue using their CPAP machines within two years of commencing treatment, often related to reasons of discomfort when wearing the mask, shares Fleetham. Some individuals may also confront barriers to accessing CPAP due to the cost of the devices, which range in price from around $800 to $3,000 and are not presently covered under the B.C. Medical Services Plan.

“Our aim is that our novel negative pressure therapy device will feel like wearing a scarf while sleeping, making it as comfortable as possible for the patient.”

Targeted to be a fraction of the cost of CPAP machines, the negative pressure therapy device would also lower the affordability barrier, enabling more individuals to benefit from a life-enhancing if not life-saving clinically approved treatment, adds Fleetham.

An approximation of what the negative pressure prototype under development could look like when worn.


Fleetham and the UBC team’s project got underway six months ago, springboarding from a COVID-19 pandemic project to identify a negative pressure treatment to treat respiratory disease. The research team anticipates moving their negative pressure therapy prototype through clinical trials and into a real-world application within the next year, with potential commercialization and patient benefits on the horizon.

This project was made possible through philanthropy. Sincere thanks to the Belzberg family, whose generous gift is fueling innovation towards improving the quality of life of patients.
 

Researchers

John Fleetham

Related Articles

Ask an expert: How does fatigue affect my ability to drive?

Brain drain: The connection between poor sleep and mild cognitive impairment

A dangerous combination, sleep apnea and irregular heart rhythm prove difficult to diagnose in tandem

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Centre for Lung Health

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy